Delivery Order SPE2DX22D0129-SPE2D826F0DEW
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $495,295.50 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $359,118.63 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $6,156.96 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The order will be performed at the company's corporate office location in Conshohocken, Pennsylvania,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,141.37 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and competitively awarded on a firm fixed-price basis, will be completed by January 20, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,200.68 on January 8, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order will be completed by January 9, 2026, and will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $124,469.46 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 14, 2026, represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $25,308.36 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The work will be performed at the...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DEWDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $45,231.48 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp supplies a broad portfolio of pharmaceutical products and medical commodities to support military and federal healthcare systems, including prescription medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. The company's competitively awarded delivery orders demonstrate its capability to efficiently fulfill government contracts for essential pharmaceutical supplies required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.2k | 1/18/26 |